Sulindac inhibits growth of rat colon carcinoma by inducing apoptosis

European Surgical Research

Volumn 32, Issue 5, 2000, Pages 305-309

  Masunaga, Reiko ^a   Kohno, H ^a   Kumar Dhar, D ^a   Kotoh, T ^a   Tachibana, M ^a   Kubota, H ^a   Nagasue, N ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Colon cancer, rats; Sulindac

Indexed keywords

SULINDAC;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0033672173     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008780     Document Type: Article

References (29)

1. Alteration of tumor growth by aspirin and indomethacin: Studies with two transplantable tumors in mouse
2. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study
3. Aspirin use and reduced risk of fatal colon cancer
4. The prevention of colorectal cancer by aspirin use
5. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors
6. Effects of sulindac on sporadic colorectal adenomatous polyps
7. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
8. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
9. Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation
10. Local immunity and metastasis of colorectal carcinoma
11. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: Mechanisms of enhancement using prostaglandin synthetase inhibitors
12. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients
13. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
14. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
15. Establishment of a rat colon cancer cell line, ACL-15: Analysis of its metastatic properties
16. Identification of programmed cell death via specific labeling of nuclear DNA fragmentation
17. Lectin histochemistry of mammalian endothelium
18. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
19. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
20. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
21. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells
22. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
23. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis
24. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
25. T cell receptor-ζ and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma
26. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma
27. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: An immunohistological analysis
28. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
29. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits